Lutetium-177: Difference between revisions

Redirect to:

Lutetium

Isotope Lutetium - 177

	Start date	Site	Title	Topic
ML24109A127	18 April 2024		M240409B: Transcript - Meeting with Advisory Committee on the Medical Uses of Isotopes	Brachytherapy Eye plaque TheraSphere
ML24274A035	8 April 2024		FY24 - NRC Staff Medical Event Slides	Brachytherapy Eye plaque TheraSphere Overdose Underdose Reactive Inspection
ML24025A055	25 January 2024		M240118: Transcript - Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines	Exemption Request Brachytherapy Backfit Machine learning Pre-submittal
ML23320A234	16 November 2023		Ots Chapter 246-221 Wac Standards (002)	High Radiation Area Deep Dose Equivalent Stolen Exclusive Use Overexposure
ML23318A248	23 October 2023		ACMUI Fall Transcript	Decommissioning Funding Plan Brachytherapy TheraSphere Overexposure Underdose
ML23241A933	23 August 2023		t180-3 Effective 2021-06-15 Highlighted	Safe Shutdown Incorporated by reference Decommissioning Funding Plan Authorized possession limits License Renewal Static Eliminator Depleted uranium
SECY-23-0062, Enclosure 2 - Proposed Rule Regulatory Analysis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials	24 July 2023		SECY-23-0062: Enclosure 2 - Proposed Rule Regulatory Analysis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials	Decommissioning Funding Plan Authorized possession limits License Renewal Exemption Request Backfit
ML23226A087	20 July 2023		Transcript of Information Meeting with Q&A Sessions on the Proposed Revision to Regulatory Guide 8.39 Release of Patients Administered Radioactive Material, Pages 1-118
ML23122A356	30 June 2023		Regulatory Basis: Rulemaking on Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material	Enforcement Discretion Decommissioning Funding Plan Exemption Request Brachytherapy TheraSphere
ML23166B091	14 June 2023		Wac Chapter 246-221 Radiation Protection Standards	High Radiation Area Deep Dose Equivalent Stolen Exclusive Use Overexposure
ML23156A532	31 May 2023		Alabama Radiation Control Rule, Licensing Rules, Chapter 420-3-2-.02	Incorporated by reference Decommissioning Funding Plan Authorized possession limits License Renewal Static Eliminator Stolen Depleted uranium
ML23125A316	15 May 2023		Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2023 Meeting Handout, May 15, 2023	Decommissioning Funding Plan Accidental discharge Brachytherapy Stolen Eye plaque TheraSphere Overdose Underdose
ML23187A489	15 May 2023		Spring 2023 Meeting Official Transcript of Meeting	Brachytherapy Stolen Eye plaque TheraSphere Overdose Underdose
ML23192A046	15 May 2023		Transcript of Advisory Committee on the Medical Uses of Isotopes, 05/15/2023, Pages 1-227	Brachytherapy Stolen Eye plaque TheraSphere Overdose Underdose
NUREG-2183, Supplement 1, Environmental Impact Statement Related to the Operating License for the Shine Medical Isotope Production Facility Final Report	31 January 2023		NUREG-2183, Supplement 1, Environmental Impact Statement Related to the Operating License for the Shine Medical Isotope Production Facility Final Report	Offsite Dose Calculation Manual License Renewal Environmental Justice Depleted uranium
ML23034A206	26 January 2023		M230126: Transcript - Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines	License Renewal Pandemic COVID-19 Reactive Inspection
ML23012A007	5 December 2022		Transcript of Meeting of the Advisory Committee on Medical Uses of Isotopes (Acmui), December 5, 2022	Enforcement Discretion Decommissioning Funding Plan Exemption Request Pandemic Brachytherapy TheraSphere
ML22326A362	22 November 2022		Draft Regulatory Basis Document for the Rulemaking to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies for ACMUI Review	Enforcement Discretion Decommissioning Funding Plan Exemption Request Brachytherapy TheraSphere
ML22243A213	30 August 2022		New Mexico Regulations Title 20 Chapter 3 Part 3 (Amended)	Incorporated by reference Decommissioning Funding Plan Authorized possession limits License Renewal Static Eliminator Depleted uranium
ML22136A108	31 May 2022		Enforcement Program Annual Report, Calendar Year 2021 (Public)	Enforcement Discretion Nondestructive Examination Significance Determination Process Pandemic Coronavirus COVID-19 Moisture Density Gauge
ML22136A225	11 May 2022		MD Regulations 26.12.01.01	Safe Shutdown High Radiation Area Contraband Incorporated by reference Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Earthquake Deep Dose Equivalent Chernobyl Brachytherapy Static Eliminator Stolen Uranium Hexafluoride Tritium Sign Exclusive Use Overexposure Depleted uranium
ML22063A454	26 April 2022		IP 87130 Nuclear Medicine Programs	Reactive Inspection
SECY-19-0125, Regulatory Basis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials (SRM-SECY-19-0125)	22 April 2022		Regulatory Basis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials (SRM-SECY-19-0125)	Decommissioning Funding Plan Exemption Request Backfit
ML22094A102	5 April 2022		Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Revised Handout	Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose
ML22179A159	5 April 2022		April 5 2022 ACMUI Spring Meeting Transcript_Draft	Tritium Exit Sign Decommissioning Funding Plan Pandemic COVID-19 Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose Potassium iodide
ML22179A066	5 April 2022		Transcript of Meeting of the Advisory Committee on Medical Use of Isotopes, April 5, 2022	Tritium Exit Sign Decommissioning Funding Plan Pandemic COVID-19 Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose Potassium iodide
ML22067A196	8 March 2022		Washington Regulations Ch 246-232	License Renewal Depleted uranium
IR 05000186/2021203	2 March 2022	University of Missouri-Columbia	the Curators of the University of Missouri U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000186/2021203
ML22060A212	28 February 2022		Maryland Regulations 26.12.01.01	Safe Shutdown High Radiation Area Contraband Incorporated by reference Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Earthquake Deep Dose Equivalent Chernobyl Brachytherapy Static Eliminator Stolen Uranium Hexafluoride Tritium Sign Exclusive Use Overexposure Depleted uranium
ML22026A365	26 January 2022		CRCPD Part D Draft	High Radiation Area Deep Dose Equivalent Brachytherapy Stolen
ML22018A078	14 January 2022		Illinois Regulations Tracked Changes 32-IAC-330	Static Eliminator Depleted uranium
ML21341B436	15 December 2021		Advisory Committee on the Medical Uses of Isotopes (ACMUI) December 15, 2021 Teleconference Meeting Handout	Brachytherapy Stolen Eye plaque
ML21327A315	22 November 2021		New Mexico Regulations 20.3.4
ML21330A012	31 October 2021	07103099	RAI Response: ISORAD-TC1 Docket No. 71-3099, 10/31/2021, SAR Updates Package (Non-Proprietary)	Nondestructive Examination Finite Element Analysis Liquid penetrant Loctite Exclusive Use Depleted uranium
ML21301A031	25 October 2021		Tennessee Regulations 0400-20-10	Safe Shutdown Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Static Eliminator Uranium Hexafluoride Exclusive Use Depleted uranium
ML21301A025	25 October 2021		Tennessee Regulations 0400-20-05	High Radiation Area Deep Dose Equivalent Chernobyl Brachytherapy Stolen Exclusive Use
ML21278B103	22 September 2021		Transcript - Fda and NRC Workshop on Enhancing Development of Targeted Alpha-Emitting Radiopharmaceuticals, Special Session on Actinium-225	Decommissioning Funding Plan Chernobyl Brachytherapy
ML21193A272	7 July 2021		Nd Chapter 33.1-10-03.1, Rules of General Applicability to Domestic Licensing of Byproduct Material	Safe Shutdown Incorporated by reference Decommissioning Funding Plan Authorized possession limits License Renewal
ML21019A159	27 January 2021	SHINE Medical Technologies	Public Meeting Summary January 12 2021	License Renewal
ML21022A027	22 January 2021	SHINE Medical Technologies	Shine Medical Technologies, LLC Application for an Operating License, Response to Environmental Requests for Additional Information	Earthquake Environmental Justice Depleted uranium
PMNS20201420, Shine Medical Technologies, LLC Operating License Application Environmental Technical Discussion	23 December 2020	SHINE Medical Technologies	Shine Medical Technologies, LLC Operating License Application Environmental Technical Discussion
ML20352A225	18 December 2020	SHINE Medical Technologies	Shine Environmental RAIs - Cumulative Impacts
ML20325A090	14 October 2020		Transcript of October 14 2020 FDA-NRC Workshop on Enhancing Novel Technologies - Radiopharmaceuticals and Radiological Devices	Decommissioning Funding Plan Pandemic COVID-19 Brachytherapy TheraSphere Depleted uranium
ML21279A215	29 February 2020	07103099	Safety Analysis Report of the ISORAD-TC1 (Letter, Dated 7/14/2021, R. Boyle, Request for Review of Canadian Certificate of Approval No. CDN/2101/B(U), Docket No. 71-3099)	Nondestructive Examination Finite Element Analysis Liquid penetrant Loctite Exclusive Use Depleted uranium
ML20030A031	28 January 2020		M200128: Transcript - Discussion of Medical Uses of Radioactive Materials (Public Meeting)	Brachytherapy TheraSphere Overexposure
NUREG-1556 Volume 9, Rev. 3, Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses Final Report	30 September 2019		NUREG-1556, Vol. 9, Rev. 3, Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses Final Report	High winds High Radiation Area Emergency Lighting Decommissioning Funding Plan License Renewal Brachytherapy Stolen Eye plaque Uranium Hexafluoride Exclusive Use TheraSphere Overexposure Affidavit Depleted uranium
ML19304B462	11 September 2019		Final Transcript of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) Meeting, September 11, 2019, Pages 1-189	Brachytherapy TheraSphere
ML19108A463	31 July 2019		Draft Regulatory Guide (DG)-8057, Release of Patients Administered Radioactive Material	Brachytherapy
ML19143A404	10 June 2019		Advisory Committee on the Medical Uses of Isotopes (ACMUI) June 10, 2019 Meeting Ebinder	Incorporated by reference Brachytherapy
ML19157A111	6 June 2019		Preliminary Draft Proposed Regulatory Guide 8.39, Release of Patients Administered Radioactive Materials, Revision 1 (Phase 1) for ACMUI Review with Note	Incorporated by reference Brachytherapy
... further results

@@ Line 1: / Line 1: @@
+#REDIRECT [[Lutetium]]
 {{Isotope-Nav
 |element=Lutetium
 |mass number=177
 }}

Lutetium-177: Difference between revisions

Revision as of 09:58, 30 July 2021

Navigation menu

Lutetium-177: Difference between revisions

Revision as of 09:58, 30 July 2021

Navigation menu

Search